☆ 4.8 Article

Correlation of antigen-specific immune response with disease severity among COVID-19 patients in Bangladesh

FRONTIERS IN IMMUNOLOGY (2022)

Related references

Note: Only part of the references are listed.

Review Immunology

The T cell immune response against SARS-CoV-2

Paul Moss

Summary: T cell immunity plays a central role in controlling SARS-CoV-2 infection, with early responses correlating with protection. T cell memory provides broad recognition of viral proteins, limiting the impact of viral variants and offering protection against severe disease. Current COVID-19 vaccines elicit robust T cell responses, contributing to the prevention of hospitalization or death. Therefore, the importance of T cell immunity may have been underestimated.

NATURE IMMUNOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts

Rhia Kundu et al.

Nature Communications (2022)

Add to Collection

Article Tropical Medicine

Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh

Afroza Akter et al.

PLoS Neglected Tropical Diseases (2022)

Add to Collection

Editorial Material Medicine, General & Internal

Efficiency decreases

Halane Vaillant-Roussel et al.

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2022)

Add to Collection

Article Multidisciplinary Sciences

T cell responses to SARS-CoV-2 spike cross-recognize Omicron

Roanne Keeton et al.

Summary: Despite reduced neutralizing antibody activity, T cell responses induced by vaccination or infection can cross-recognize the Omicron variant and provide protection.

NATURE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Exploring the Utility of NK Cells in COVID-19

Xuewen Deng et al.

Summary: NK cells play a crucial role in determining the course of COVID-19, and their dysregulation may contribute to disease progression. NK cell-based therapies with antiviral and antifibrotic activity could be a potential strategy for the treatment of COVID-19.

BIOMEDICINES (2022)

Add to Collection

Review Medicine, General & Internal

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

Daniel R. Feikin et al.

Summary: This study systematically reviewed the duration of protection provided by COVID-19 vaccines against various clinical outcomes. The findings indicate that the effectiveness or efficacy of the vaccines decreased from 1 to 6 months after full vaccination, but remained high against severe disease. Evaluating the effectiveness or efficacy of vaccines beyond 6 months is crucial for updating vaccine policies.

LANCET (2022)

Add to Collection

Article Microbiology

Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh

Mokibul Hassan Afrad et al.

Summary: The study reported the coding-complete genome sequences of 15 SARS-CoV-2 sublineage B.1.617.2 strains obtained from Bangladeshi individuals with recent travel history to India and from the Bangladeshi community. Genomic data were generated using Nanopore sequencing approach developed by the ARTIC Network.

MICROBIOLOGY RESOURCE ANNOUNCEMENTS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Adaptive immunity to SARS-CoV-2 and COVID-19

Alessandro Sette et al.

Summary: The adaptive immune system, consisting of B cells, CD4(+) T cells, and CD8(+) T cells, plays varying roles in different viral infections and vaccines. Studies are showing that CD4(+) T cells, CD8(+) T cells, and neutralizing antibodies all play a part in controlling SARS-CoV-2 in COVID-19 cases, emphasizing the importance of understanding adaptive immunity in combating the disease.

CELL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Katie J. Ewer et al.

Summary: A single dose of the ChAdOx1 nCoV-19 vaccine can induce favorable immune responses that may help control or prevent SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Add to Collection

Article Immunology

Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity

Heloise Flament et al.

Summary: Severe cases of COVID-19 are characterized by immune system dysfunction, particularly a significant reduction and high activation of mucosal-associated invariant T (MAIT) cells. These cells play a crucial role in disease severity and mortality, correlating with the activation of inflammatory cytokines and cytotoxic phenotype.

NATURE IMMUNOLOGY (2021)

Add to Collection

Review Infectious Diseases

Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis

Qiao Liu et al.

Summary: This study included 58 studies, with the effectiveness of a single dose vaccine in preventing SARS-CoV-2 infections at 41% and two doses reaching 85% effectiveness. The vaccines are generally safe and help reduce the incidence of COVID-19-related deaths and severe cases.

INFECTIOUS DISEASES OF POVERTY (2021)

Add to Collection

Article Immunology

Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses

Emelie Marklund et al.

Summary: The study found that healthcare workers caring for COVID-19 patients in Sweden have a higher rate of SARS-CoV-2 infection compared to blood donors. There is significant variation between different IgG assays, suggesting that multiple serological targets should be used to confirm past infection. CD4(+) T-cell reactivity is not a suitable measure of past infection and does not reliably indicate protection from infection in naive individuals.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine

Annalisa Ciabattini et al.

Summary: The study found that spike-specific antibodies and memory B cells still persisted up to 6 months after BNT162b2 vaccine administration, indicating a lasting immune protection against SARS-CoV-2 virus.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination

Lucie Loyal et al.

Summary: The study demonstrates that preexisting spike-cross-reactive T cells play a functional role in the immune response to SARS-CoV-2 infection and vaccination. Cross-reactive immunity may explain the rapid induction of immunity after primary SARS-CoV-2 immunization and the high rate of asymptomatic or mild COVID-19 cases.

SCIENCE (2021)

Add to Collection

News Item Infectious Diseases

The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh

Mustafizur Rahman et al.

TRANSBOUNDARY AND EMERGING DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery

Chengqian Feng et al.

Summary: The study found that SARS-CoV-2 specific immune response can persist to some extent up to 1 year after recovery from COVID-19, with serum neutralizing capacity decreasing but remaining stable. Viral-specific cellular immune protection persists between 6 months and 12 months after recovery.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Microbiology

Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges

Al Hakim et al.

Summary: COVID-19, caused by SARS-CoV-2, shows high variability in clinical manifestations and post-disease complications, with age and comorbidities playing a significant role in disease severity.

FRONTIERS IN MICROBIOLOGY (2021)

Add to Collection

Article Microbiology

Genomics, social media and mobile phone data enable mapping of SARS-CoV-2 lineages to inform health policy in Bangladesh

Lauren A. Cowley et al.

Summary: Genomic analysis in Bangladesh revealed the initial emergence and spread of SARS-CoV-2 lineages, with significant impact from population mobility and inter-city travel, highlighting the importance of monitoring viral diversity and controlling within-country movement to limit transmission rates.

NATURE MICROBIOLOGY (2021)

Add to Collection

Article Cell Biology

Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis

Bolin Wang et al.

AGING-US (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Alba Grifoni et al.

CELL (2020)

Add to Collection

Article Microbiology

A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2

Alba Grifoni et al.

CELL HOST & MICROBE (2020)

Add to Collection

Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

Add to Collection

Review Immunology

The COVID-19 Cytokine Storm; What We Know So Far

Dina Ragab et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome

Daniela Weiskopf et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections

Ger Rijkers et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

Divij Mathew et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses

He-wei Jiang et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Immunology

MAIT cell activation and dynamics associated with COVID-19 disease severity

Tiphaine Parrot et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Natural killer cell immunotypes related to COVID-19 disease severity

Christopher Maucourant et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Cell Biology

Recurrent group A Streptococcus tonsillitis is an immunosusceptibility disease involving antibody deficiency and aberrant TFH cells

Jennifer M. Dan et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Add to Collection

Article Immunology

Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease

Antigoni Morou et al.

NATURE IMMUNOLOGY (2019)

Add to Collection

Article Immunology

Monitoring t-cell responses in translational studies: optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-specific responses

Anja Ten Brinke et al.

FRONTIERS IN IMMUNOLOGY (2017)

Add to Collection

Article Immunology

Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells

Ramin Sedaghat Herati et al.

SCIENCE IMMUNOLOGY (2017)

Add to Collection

Article Immunology

A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood

Jennifer M. Dan et al.

JOURNAL OF IMMUNOLOGY (2016)

Add to Collection

Article Multidisciplinary Sciences

Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines

Steven G. Smith et al.

PLOS ONE (2015)

Add to Collection

Review Immunology

ELISpot for measuring human immune responses to vaccines

Meredith Siota et al.

EXPERT REVIEW OF VACCINES (2011)

Add to Collection

Article Medicine, Research & Experimental

Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals

Laurel Yong-Hwa Lee et al.

JOURNAL OF CLINICAL INVESTIGATION (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.